Yaron Ilan

655 total citations
30 papers, 555 citations indexed

About

Yaron Ilan is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Yaron Ilan has authored 30 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in Yaron Ilan's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (4 papers) and Immune Cell Function and Interaction (3 papers). Yaron Ilan is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (4 papers) and Immune Cell Function and Interaction (3 papers). Yaron Ilan collaborates with scholars based in Israel, United States and Denmark. Yaron Ilan's co-authors include Ruslana Alper, Judith Diment, Namita Roy Chowdhury, Israel Gotsman, Hidetsugu Saito, Elazar Rabbani, Dean Engelhardt, Tawfik Khoury, Ronen Levi and Sarah Weksler‐Zangen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Yaron Ilan

29 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaron Ilan Israel 13 207 165 148 115 91 30 555
Fang Xiao China 14 168 0.8× 172 1.0× 200 1.4× 87 0.8× 43 0.5× 52 690
Michio Sata Japan 14 66 0.3× 182 1.1× 188 1.3× 162 1.4× 69 0.8× 60 605
Weimin She China 11 230 1.1× 302 1.8× 136 0.9× 183 1.6× 46 0.5× 14 585
Kyoko Tomita Japan 16 101 0.5× 340 2.1× 304 2.1× 184 1.6× 100 1.1× 32 772
Zhi Pang China 14 115 0.6× 134 0.8× 269 1.8× 34 0.3× 158 1.7× 30 655
Daniel A. Giles United States 13 265 1.3× 374 2.3× 201 1.4× 93 0.8× 170 1.9× 19 804
Toshio Sakiyama Japan 15 178 0.9× 174 1.1× 222 1.5× 44 0.4× 54 0.6× 26 648
P Erwin United Kingdom 13 99 0.5× 110 0.7× 251 1.7× 91 0.8× 93 1.0× 17 759
G.C. Naccari Italy 5 268 1.3× 175 1.1× 218 1.5× 30 0.3× 320 3.5× 5 762
Jianhong Chen China 16 71 0.3× 208 1.3× 188 1.3× 81 0.7× 49 0.5× 58 680

Countries citing papers authored by Yaron Ilan

Since Specialization
Citations

This map shows the geographic impact of Yaron Ilan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaron Ilan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaron Ilan more than expected).

Fields of papers citing papers by Yaron Ilan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaron Ilan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaron Ilan. The network helps show where Yaron Ilan may publish in the future.

Co-authorship network of co-authors of Yaron Ilan

This figure shows the co-authorship network connecting the top 25 collaborators of Yaron Ilan. A scholar is included among the top collaborators of Yaron Ilan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaron Ilan. Yaron Ilan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ilan, Yaron, et al.. (2025). Inter-organ correlations in inflammation regulation: a novel biological paradigm in a murine model. Journal of Medicine and Life. 18(1). 67–72. 2 indexed citations
2.
Adar, Tomer, et al.. (2023). Increased hepatic Akt phosphorylation alleviated glucose intolerance and improved liver function in leptin-deficient mice. Clinical and Experimental Hepatology. 9(2). 154–171. 1 indexed citations
3.
Khoury, Tawfik, et al.. (2016). The gut‐kidney axis in chronic renal failure: A new potential target for therapy. Hemodialysis International. 21(3). 323–334. 48 indexed citations
4.
Zigmond, Ehud, Ami Ben Yaʼacov, Hyunbeom Lee, et al.. (2015). Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase. ACS Medicinal Chemistry Letters. 6(8). 840–844. 40 indexed citations
5.
Zigmond, Ehud, Oshrat E Tayer-Shifman, Gadi Lalazar, et al.. (2014). β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model. SHILAP Revista de lepidopterología. 11 indexed citations
6.
Margalit, Maya, Ruslana Alper, Eran Elinav, et al.. (2005). Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 289(5). G917–G925. 62 indexed citations
7.
Shibolet, Oren, Ruslana Alper, Yaron Ilan, & Joseph Weidenfeld. (2005). Regulatory Role of the Pituitary-Adrenal Axis in Experimental Colitis: Effect of Adrenalectomy on the Clinical Course and the TH1/TH2 Immune Profile. Inflammatory Bowel Diseases. 11(12). 1053–1059. 13 indexed citations
8.
Shibolet, Oren, Eran Elinav, Yaron Ilan, et al.. (2004). REDUCED INCIDENCE OF HYPERURICEMIA, GOUT, AND RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION IN COMPARISON TO HEART TRANSPLANTATION: A LONG-TERM FOLLOW-UP STUDY. Transplantation. 77(10). 1576–1580. 14 indexed citations
9.
Elinav, Hila, Alexander Maly, Yaron Ilan, et al.. (2004). The coexistence of Sweet's syndrome and Still's disease—is it merely a coincidence?. Journal of the American Academy of Dermatology. 50(5). 90–92. 15 indexed citations
10.
Elinav, Hila, Eran Israeli, Oren Shibolet, et al.. (2004). Idiopathic liver involvement in Turner syndrome.. PubMed. 6(1). 56–7. 2 indexed citations
11.
Alper, Ruslana, et al.. (2001). Pregnancy rate and embryo loss in the NK1.1+ T cell-depleted mouse.. PubMed. 46(1). 54–60. 1 indexed citations
12.
Israeli, Eran, E. Galun, Yaron Ilan, et al.. (2001). Combination therapy for hepatitis C virus reinfection after orthoptic liver transplantation. Transplantation Proceedings. 33(6). 2929–2929. 3 indexed citations
13.
Gotsman, Israel, Roy Beinart, Ruslana Alper, et al.. (2000). Induction of oral tolerance towards hepatitis B envelope antigens in a murine model. Antiviral Research. 48(1). 17–26. 23 indexed citations
14.
Alper, Ruslana, et al.. (2000). Enhancement of immune tolerance via induction of NK1.1 positive liver-associated-lymphocytes under immunosuppressive conditions. Journal of Hepatology. 32(5). 812–820. 19 indexed citations
15.
Ilan, Yaron, Sarah Weksler‐Zangen, Shomron Ben‐Horin, et al.. (2000). Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. The American Journal of Gastroenterology. 95(4). 966–973. 57 indexed citations
16.
Gotsman, Israel, et al.. (1999). Liver–Associated Lymphocytes Expressing Nk1.1 Are Essential for Oral Immune Tolerance Induction in A Murine Model. Hepatology. 29(3). 746–755. 88 indexed citations
17.
Ilan, Yaron, et al.. (1999). Adenovirus-mediated Gene Therapy of Liver Diseases. Seminars in Liver Disease. 19(1). 49–59. 73 indexed citations
18.
Toren, Amos, et al.. (1997). Impaired liver function tests in patients treated with antithymocyte globulin: Implication for liver transplantation. Medical Oncology. 14(3-4). 125–129. 3 indexed citations
19.
Ilan, Yaron, et al.. (1996). Sanctuary of hepatitis B virus in bone-marrow cells of patients undergoing liver transplantation. Liver Transplantation and Surgery. 2(3). 206–210. 16 indexed citations
20.
Ilan, Yaron & Ofer Gemer. (1988). Papaverine-induced coma. European Journal of Clinical Pharmacology. 33(6). 651–651. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026